Gufic Biosciences LimitedNSE: GUFICBIO

Press Release Sep 11 2023

· Issued by Gufic Biosciences Limited

Filed with NSE ·

Gufic Biosciences Limited has informed the Exchange regarding a press release dated September 11, 2023, titled "Press Release Gufic receives approval of TGA, Australia and ANVISA, Brazil for Parecoxib 40mg injection ".

View Attachment

6ix hasn’t read this filing yet.

Gufic Biosciences Limited on 6ix

Earlier from Gufic Biosciences

All Gufic Biosciences news releases